Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization (Q33929011)

30 July 2017

Disruption of TGF-beta growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization (English)

1 reference

30 July 2017

7

Lodish HF

1 reference

30 July 2017

Liu X

1

1 reference

30 July 2017

Sun Y

2

1 reference

30 July 2017

Ehrlich M

3

1 reference

30 July 2017

Lu T

4

1 reference

30 July 2017

Kloog Y

5

1 reference

30 July 2017

Weinberg RA

6

1 reference

30 July 2017

Henis YI

8

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

30 July 2017

1 reference

30 July 2017

19

1 reference

30 July 2017

51

1 reference

30 July 2017

5926-5935

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203991

30 July 2017

0 references

cites work

Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Activation of the erythropoietin receptor by the gp55-P viral envelope protein is determined by a single amino acid in its transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Loss of functional cell surface transforming growth factor beta (TGF-beta) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Dislodgment and accelerated degradation of Ras.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Cdk phosphorylation triggers sequential intramolecular interactions that progressively block Rb functions as cells move through G1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

p53 gene mutation and integrated hepatitis B viral DNA sequences in human liver cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Synergistic cooperation of TFE3 and smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Growth inhibition by transforming growth factor beta (TGF-beta) type I is restored in TGF-beta-resistant hepatoma cells after expression of TGF-beta receptor type II cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Membrane interactions of a constitutively active GFP-Ki-Ras 4B and their role in signaling. Evidence from lateral mobility studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

CDK inhibitors: positive and negative regulators of G1-phase progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

The geranylgeranyltransferase I inhibitor GGTI-298 induces hypophosphorylation of retinoblastoma and partner switching of cyclin-dependent kinase inhibitors. A potential mechanism for GGTI-298 antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Hepatocyte growth factor releases mink epithelial cells from transforming growth factor beta1-induced growth arrest by restoring Cdk6 expression and cyclin E-associated Cdk2 activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Distinct roles for cyclin-dependent kinases in cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G(1) arrest pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Signaling activity of transforming growth factor beta type II receptors lacking specific domains in the cytoplasmic region

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

A new functional Ras antagonist inhibits human pancreatic tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

7 January 2021

Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

7 January 2021

Specificity, diversity, and regulation in TGF-beta superfamily signaling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

7 January 2021

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203991

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1203991

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference